![]() |
|
|
Vol. 298, Issue 1, 264-271, July 2001
Division of Pharmaceutics, College of Pharmacy (S.-N.H., P.W.S.),
and The Ohio State Biophysics Program (P.W.S.), The Ohio State
University, Columbus, Ohio
Riboflavin (vitamin B2) is essential for fetal development
and must be acquired from maternal sources. The uptake mechanism of
riboflavin and the major regulatory pathways involved were characterized in a model for the placental barrier, the human choriocarcinoma cell line, BeWo. Uptake of [3H]riboflavin
was saturable (Kt = 1.32 ± 0.68 nM, Jmax = 266.63 ± 26.89 fmol/mg
of protein/20 min), and was significantly reduced at low temperature
and in the presence of metabolic inhibitors (azide, 2-deoxyglucose) or
structural analogs. Ouabain, amiloride, sodium-free buffers, and medium
with pH values ranging from 3 to 8 did not affect uptake of
[3H]riboflavin. In contrast, substitution of chloride
with other monovalent anions significantly inhibited its uptake.
Induced differentiation of BeWo cells into syncytiotrophoblasts by
forskolin or 8-bromo-cyclic adenosine monophosphate introduced a
time-dependent decrease of riboflavin uptake. Preincubation with
activators of cyclic nucleotide-dependent protein kinase pathways
(3-isobutyl-1-methylxanthine and
p-chlorophenylthio-cyclic guanosine monophosphate) and
calmodulin antagonists (calmidazolium and W-13) resulted in a
concentration-dependent reduction of [3H]riboflavin
uptake, whereas specific modulators of protein kinase C pathways did
not have significant effects. 3-Isobutyl-1-methylxanthine exerted its
regulatory effect on riboflavin uptake via decreasing both
Kt and Jmax of
the riboflavin uptake process (Kt = 6.32 ± 1.29 nM, Jmax = 135.57 ± 10.42 fmol/mg of protein/20 min). In summary, we report
the presence of high- affinity riboflavin transporter(s) on the
microvillous membrane of BeWo cells that appears to be modulated by
cellular cyclic nucleotide levels and calmodulin.
This article has been cited by other articles:
![]() |
A. Yonezawa, S. Masuda, T. Katsura, and K.-i. Inui Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1 Am J Physiol Cell Physiol, September 1, 2008; 295(3): C632 - C641. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Foraker, A. Ray, T. C. Da Silva, L. M. Bareford, K. M. Hillgren, T. D. Schmittgen, and P. W. Swaan Dynamin 2 Regulates Riboflavin Endocytosis in Human Placental Trophoblasts Mol. Pharmacol., September 1, 2007; 72(3): 553 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Mason, V. M. D'Souza, L. M. Bareford, M. A. Phelps, A. Ray, and P. W. Swaan Recognition, Cointernalization, and Recycling of an Avian Riboflavin Carrier Protein in Human Placental Trophoblasts J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhou, K. Tanaka, M. J. Soares, and G. You Characterization of an organic anion transport system in a placental cell line Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1103 - E1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Huang, M. A. Phelps, and P. W. Swaan Involvement of Endocytic Organelles in the Subcellular Trafficking and Localization of Riboflavin J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 681 - 687. [Abstract] [Full Text] [PDF] |
||||